FXAIX
Price
$261.18
Change
-$2.08 (-0.79%)
Updated
Jul 13 closing price
Net Assets
827.51B
GSRCX
Price
$12.26
Change
+$0.03 (+0.25%)
Updated
Jul 10 closing price
Net Assets
408.34M
Interact to see
Advertisement

FXAIX vs GSRCX

FXAIX vs GSRCX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. GSRCX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and GSRCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 828B vs. GSRCX (408M). FXAIX pays higher dividends than GSRCX: FXAIX (1.04) vs GSRCX (0.60). FXAIX was incepted earlier than GSRCX: FXAIX (15 years) vs GSRCX (21 years). GSRCX (2.04) is less costly to investors than FXAIX (0.01). GSRCX is a more actively managed with annual turnover of: 35.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than GSRCX: FXAIX (0) vs GSRCX (1000). FXAIX annual gain was more profitable for investors over the last year : 22.46 vs. GSRCX (2.96). FXAIX return over 5 years is better than : 85.95 vs. GSRCX (-4.46).
FXAIXGSRCXFXAIX / GSRCX
Total Expense Ratio0.011.761%
Annual Report Gross Expense Ratio0.012.041%
Fund Existence15 years21 years-
Gain YTD11.35011.79296%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets828B408M202,941%
Annual Yield % from dividends1.040.60174%
Returns for 1 year22.462.96758%
Returns for 3 years74.977.75967%
Returns for 5 years85.95-4.46-1,928%
Returns for 10 years288.22-35.27-817%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPIX6.540.61
+10.29%
Cumberland Pharmaceuticals
BKV25.790.49
+1.94%
BKV Corp
XRTX2.03-0.02
-0.98%
XORTX Therapeutics Inc.
ORN13.35-0.38
-2.77%
Orion Group Holdings
JAZZ236.97-6.85
-2.81%
Jazz Pharmaceuticals plc